AMERICAN BATTERY TECHNOLOGY Co current report, 15 March 2024

Business Context and Reporting Period

This Form 8-K Current Report was filed by American Battery Technology Company (ABAT) on March 15, 2024. The filing addresses Item 5.02 regarding the amendment of compensatory arrangements for certain officers. The company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market LLC under the symbol ABAT.

Key Financial Metrics

This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on executive compensation adjustments.

Material Changes

On March 15, 2024, the Company entered into amended offer letters with three key executives, allowing them to elect equity instruments in lieu of cash compensation:

  • Ryan Melsert (CEO, CTO, Director): Elected to receive 75,000 RSUs and 75,000 warrants (5-year expiration, $2.00 exercise price) in lieu of $150,000 cash.
  • Andrés Meza (COO): Elected to receive 50,000 RSUs and 50,000 warrants (5-year expiration, $2.00 exercise price) in lieu of $100,000 cash.
  • Scott Jolcover (CRO): Elected to receive 11,500 RSUs and 11,500 warrants (5-year expiration, $2.00 exercise price) in lieu of $23,000 cash.

All RSUs and warrants vest immediately upon the executives becoming entitled to receive the corresponding cash compensation amounts.

Guidance, Outlook, and Risks

The filing does not provide updated financial guidance, management outlook, or discuss new material risks or contingencies. The primary disclosure is the modification of executive compensation structures to include equity components.

Investor Verification Checklist

  • Verify the total number of new shares/warrants authorized for issuance (136,500 RSUs and 136,500 warrants).
  • Confirm the impact of these equity grants on the company's fully diluted share count.
  • Review the full text of the Amended Offer Letters (Exhibits 10.1, 10.2, and 10.3) for additional vesting conditions or clawback provisions.
  • Assess the cash flow benefit to the company resulting from the deferral of $273,000 in cash compensation.